These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33853365)

  • 21. The Preventive Effect of Alprostadil on the Contrast-Induced Nephropathy of Coronary Heart Disease Treated by Percutaneous Coronary Intervention in Moderate and High-Risk Population Stratified by Mehran Score.
    Liu X; Zhang P; Zhang J; Zhang X; Yang S; Fu N
    Angiology; 2022 Jan; 73(1):33-41. PubMed ID: 34098771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renoprotective effect of alprostadil in combination with statins in patients with mild to moderate renal failure undergoing coronary angiography.
    Liu WJ; Zhang BC; Guo R; Wei YD; Li WM; Xu YW
    Chin Med J (Engl); 2013; 126(18):3475-80. PubMed ID: 24034093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
    Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
    Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
    Vasheghani-Farahani A; Sadigh G; Kassaian SE; Khatami SM; Fotouhi A; Razavi SA; Mansournia MA; Yamini-Sharif A; Amirzadegan A; Salarifar M; Sadeghian S; Davoodi G; Borumand MA; Esfehani FA; Darabian S
    Am J Kidney Dis; 2009 Oct; 54(4):610-8. PubMed ID: 19619921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 20-Hour preprocedural hydration is not superior to 5-hour preprocedural hydration in the prevention of contrast-induced increases in serum creatinine and cystatin C.
    Torigoe K; Tamura A; Watanabe T; Kadota J
    Int J Cardiol; 2013 Sep; 167(5):2200-3. PubMed ID: 22717305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.
    Mehran R; Faggioni M; Chandrasekhar J; Angiolillo DJ; Bertolet B; Jobe RL; Al-Joundi B; Brar S; Dangas G; Batchelor W; Prasad A; Gurm HS; Tumlin J; Stone GW
    JACC Cardiovasc Interv; 2018 Aug; 11(16):1601-1610. PubMed ID: 30139467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.
    Hölscher B; Heitmeyer C; Fobker M; Breithardt G; Schaefer RM; Reinecke H
    Can J Cardiol; 2008 Nov; 24(11):845-50. PubMed ID: 18987758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention.
    Wu H; Li D; Fang M; Han H; Wang H
    J Clin Pharmacol; 2015 Feb; 55(2):123-31. PubMed ID: 25310898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alprostadil plays a protective role in contrast-induced nephropathy in the elderly.
    Miao Y; Zhong Y; Yan H; Li W; Wang BY; Jin J
    Int Urol Nephrol; 2013 Aug; 45(4):1179-85. PubMed ID: 23860961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of oral hydration in preventing contrast-induced acute kidney injury in patients undergoing coronary angiography or intervention: a pairwise and network meta-analysis.
    Zhang W; Zhang J; Yang B; Wu K; Lin H; Wang Y; Zhou L; Wang H; Zeng C; Chen X; Wang Z; Zhu J; Songming C
    Coron Artery Dis; 2018 Jun; 29(4):286-293. PubMed ID: 29381498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions.
    Wróbel W; Sinkiewicz W; Gordon M; Woźniak-Wiśniewska A
    Kardiol Pol; 2010 Sep; 68(9):1015-20. PubMed ID: 20859892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial.
    Menting TP; Sterenborg TB; de Waal Y; Donders R; Wever KE; Lemson MS; van der Vliet JA; Wetzels JF; SchultzeKool LJ; Warlé MC
    Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):527-32. PubMed ID: 26015372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.
    Nawa T; Nishigaki K; Kinomura Y; Tanaka T; Yamada Y; Kawasaki M; Minatoguchi S
    Int J Cardiol; 2015 Sep; 195():228-34. PubMed ID: 26048382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
    Marenzi G; Ferrari C; Marana I; Assanelli E; De Metrio M; Teruzzi G; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
    JACC Cardiovasc Interv; 2012 Jan; 5(1):90-7. PubMed ID: 22230154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.
    Qian G; Fu Z; Guo J; Cao F; Chen Y
    JACC Cardiovasc Interv; 2016 Jan; 9(1):89-96. PubMed ID: 26685074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study.
    Albabtain MA; Almasood A; Alshurafah H; Alamri H; Tamim H
    J Interv Cardiol; 2013 Feb; 26(1):90-6. PubMed ID: 22994682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
    Ma WQ; Zhao Y; Wang Y; Han XQ; Zhu Y; Liu NF
    Int Urol Nephrol; 2018 Jun; 50(6):1085-1095. PubMed ID: 29404930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.
    Oguzhan N; Cilan H; Sipahioglu M; Unal A; Kocyigit I; Kavuncuoglu F; Arikan T; Akpek M; Elcik D; Sahin O; Gulme E; Pala C; Tokgoz B; Utas C; Oguzhan A; Oymak O
    Ren Fail; 2013; 35(4):434-9. PubMed ID: 23413781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty.
    Mueller C; Buerkle G; Buettner HJ; Petersen J; Perruchoud AP; Eriksson U; Marsch S; Roskamm H
    Arch Intern Med; 2002 Feb; 162(3):329-36. PubMed ID: 11822926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between prophylactic hydration volume and risk of contrast-induced nephropathy after emergent percutaneous coronary intervention.
    Cui T; Zhao J; Bei W; Li H; Tan N; Wu D; Wang K; Guo X; Liu Y; Duan C; Chen S; Lin K; Liu Y
    Cardiol J; 2017; 24(6):660-670. PubMed ID: 28394010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.